CITIGROUP INC

Position in CADL — Candel Therapeutics, Inc.

CIK 831001 NEW YORK, NY

Position in CADL

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$104,771

+$89,664 QoQ

Shares Held

21,382

+699.6% QoQ

Ownership

0.029%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

14 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

CITIGROUP INC holds $1,427,117,007 across 402 Biotechnology names. CADL ranks #207 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	682,807	$304,900,636
2	REGN	Regeneron Pharmaceuticals, Inc.	184,691	$142,699,654
3	ALNY	Alnylam Pharmaceuticals, Inc.	263,375	$87,142,884
4	MRNA	Moderna, Inc.	1,480,034	$75,185,727
5	FOLD	AMICUS THERAPEUTICS, INC.	4,226,882	$61,120,713
6	BBIO	BridgeBio Pharma, Inc.	746,483	$55,433,827
7	INCY	Incyte Corp	489,649	$46,085,763
8	ROIV	Roivant Sciences Ltd.	1,536,110	$42,550,246

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$104,771	21,382	+699.6%	Shares	Defined	2026-05-11
2025-12-31	$15,107	2,674	+56.3%	Shares	Defined	2026-02-13
2025-09-30	$8,724	1,711	-87.7%	Shares	Defined	2025-11-10
2025-06-30	$70,510	13,935	-31.1%	Shares	Defined	2025-08-11
2025-03-31	$114,343	20,238	+8.8%	Shares	Defined	2025-05-12
2024-12-31	$161,473	18,603	+28.4%	Shares	Defined	2025-02-12
2024-09-30	$100,415	14,490	+215.1%	Shares	Defined	2024-11-12
2024-06-30	$28,507	4,598	-96.1%	Shares	Defined	2024-08-12
2023-06-30	$149,451	118,612	+33596.6%	Shares	Defined	2023-08-10
2022-12-31	$630	352	+5.1%	Shares	Defined	2023-02-09
2022-09-30	$1,051	335	-22.1%	Shares	Defined	2022-11-10
2022-06-30	$1,393	430	-29.5%	Shares	Defined	2022-08-10
2022-03-31	$3,104	610	-29.6%	Shares	Defined	2022-05-12
2021-12-31	$6,772	866	—	Shares	Defined	2022-02-10
No filing history on record for this holder in this stock.